regulation The executive director of the board bringing together multinational and local drug manufacturers talks about the chamber’s goal to position the pharmaceutical industry as the most important manufacturing sector in Mexico, how the chamber is working with the government and its membership to reach this goal and which new dynamics are…
Spain Spain has seen a number of investments in recent months in the pharmaceutical sector: below is a non-comprehensive list of R&D, manufacturing, and clinical trials by international pharma companies.
Spain The following graph shows that the pharma is the leading sector when it comes to R&D in Spain, accounting for 20.2 percent of investment in 2013.
Spain The following infographic shows the main locations of the pharma sector in Spain, as well as the number of companies based in each region of the country.
Spain The following ranking comes from April 2014, and provides a snapshot of the current top players in the Spanish pharma sector.
Spain Spain’s public expenditure on pharmaceuticals is today at the same level that it was in 1993 – the lowest in 20 years.
Sanofi The director general of the Argentina, Uruguay and Paraguay region for Sanofi discusses the strength of the Argentinian healthcare system and the key, but subdued, role that multinational pharmaceutical companies play within it. As someone who comes from abroad, how would you describe the environment here for multinationals?…
cardiology The general manager of Argentia weighs up the factors that have led to his company consolidating its different business lines and becoming one of the fastest growing companies in Argentina. What was your main objective upon joining Argentia? In 1995, Argentia was acquired by BMS and was sold to…
Sanofi Sanofi’s general manager for Malaysia, Singpoare and Brunei discusses the benefits of implementing of a new channel business model and proudly showcases the dengue vaccine, 20 years after the company initiated its research. In 2010, Sanofi was undergoing a transformation to become a more diversified healthcare player. Could you tell…
distribution José Antonio Crespo became general manager for Beckman Coulter Iberia in July 2013, following an extensive career at Siemens. He discusses the structural changes associated with the company’s acquisition by Danaher, and outlines targets for growth in the coming years. What initial challenges did you face at the beginning…
women's health Leandro Sigman, general manager of Chemo, discusses changes in the Spanish market and the company’s strategy to target international markets. The crisis has changed the way companies operate in Spain, but Chemo has continued to succeed. What have been some of the key strategies employed? It has been a…
innovation Hugo Sigman explains how understanding problems in the same way as opportunities helped his company to become what is today, a successful Argentinian conglomerate where life and science is the backbone of multiple businesses. Please start by describing the Insud group as it stands today, and where it operates.…
See our Cookie Privacy Policy Here